phesgo solution
hoffmann-la roche limited - trastuzumab; pertuzumab - solution - 60mg; 60mg - trastuzumab 60mg; pertuzumab 60mg - antineoplastic agents
bimzelx solution
ucb canada inc - bimÉkizumab - solution - 160mg - bimÉkizumab 160mg
bimzelx solution
ucb canada inc - bimÉkizumab - solution - 160mg - bimÉkizumab 160mg
nucala solution
glaxosmithkline inc - mépolizumab - solution - 40mg - mépolizumab 40mg
ultomiris solution
alexion pharma gmbh - ravulizumab - solution - 300mg - ravulizumab 300mg
ultomiris solution
alexion pharma gmbh - ravulizumab - solution - 1100mg - ravulizumab 1100mg
alhemo solution
novo nordisk canada inc - concizumab - solution - 15mg - concizumab 15mg
alhemo solution
novo nordisk canada inc - concizumab - solution - 60mg - concizumab 60mg
alhemo solution
novo nordisk canada inc - concizumab - solution - 150mg - concizumab 150mg
alhemo solution
novo nordisk canada inc - concizumab - solution - 300mg - concizumab 300mg